RANDOMIZED CLINICAL TRIAL OF ANTITHYMOCYTE GLOBULIN INDUCTION IN RENAL TRANSPLANTATION COMPARING A FIXED DAILY DOSE WITH DOSE ADJUSTMENT ACCORDING TO T CELL MONITORING-Reference-Cited by-同舟云学术

RANDOMIZED CLINICAL TRIAL OF ANTITHYMOCYTE GLOBULIN INDUCTION IN RENAL TRANSPLANTATION COMPARING A FIXED DAILY DOSE WITH DOSE ADJUSTMENT ACCORDING TO T CELL MONITORING

Published:1995-06 Issue:11 Volume:59 Page:1564-1567
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

ABOUNA GEORGE M.,AL-ABDULLAH ISMAIL H.,KELLY-SULLIVAN DAWN,ANIL KUMAR M. S.,LOOSE JEFFREY,PHILLIPS KIM,YOST SAMUEL,SEIRKA DEBRA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation;Cytometry Part B: Clinical Cytometry;2024-06-28

2. Interruption of anti-thymocyte globuline treatment in solid organ transplantation is effectively monitored through a low total lymphocyte count;Frontiers in Immunology;2024-06-12

3. Single-dose antithymocyte globulin in standard immunological risk kidney transplant recipients: efficacy and kinetics of peripheral blood CD3+ T lymphocyte modulation;Journal of Nephrology;2023-11-09

4. Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic;Annals of Transplantation;2021-09-16

5. Effectiveness and safety of two different antithymocyte globulins used in induction therapy in kidney transplant recipients: A single‐center experience;Clinical Transplantation;2019-08-30